Ronit Satchi-Fainaro is a full Professor at Tel Aviv University, where she is Head of The Gray School of Medical Sciences, Head of the Cancer Research & Nanomedicine Laboratory, Founding Head of the School of Medicine Research, Director of the Cancer Biology Research Center, and Director of the TAU Kahn 3D BioPrinting Initiative. She received her B.Pharm. from the Hebrew University in Jerusalem and her Ph.D. in Polymer Chemistry & Nanotechnology from UCL, followed by a Postdoctoral Fellowship on Cancer & Vascular Biology at Harvard University and Children’s Hospital Boston. She has published more than 160 manuscripts, 13 book chapters, edited 2 books, and is an inventor on 95 patents, some of which were licensed to Pharmaceutical and Biotech companies. She founded three spin-off companies, initiated 2 clinical trials in Sheba Medical Center, and is actively engaged in translational research with several industry partners and in science outreach. Her multidisciplinary research laboratory focuses on basic research elucidating the mechanisms underlying the switch from cancer dormancy to metastatic disease, leading to the discovery of new molecular targets to interrupt tumor-host interactions. Her approach is followed by the design of targeted molecules integrating engineering, biology, chemistry, medicine, bioinformatics, and nanotechnology to guide drugs into pathological sites.